Group One Trading, L.P. Adagio Therapeutics, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	N/A	1,600 New	1,600 $5,000
Q4 2022 Feb 09, 2023	SELL	$3.08 - $4.05 $47,432 - $62,370	-15,400 Reduced 86.35%	2,435 $8,000
Q3 2022 Nov 09, 2022	BUY	$2.97 - $4.83 $25,135 - $40,876	8,463 Added 90.3%	17,835 $56,000
Q2 2022 Aug 11, 2022	BUY	$2.54 - $4.52 $23,804 - $42,361	9,372 New	9,372 $31,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.